TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/01/2024
Voltar para busca
Dado oficial do USPTO
ACCEL CLINICAL SERVICES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ACCEL CLINICAL SERVICES
ST13
US500000077789409Classe
35, 41, 42, 45
Pedido
77789409
Registro
3774386
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
29/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 45
Data de depósito
24/07/2009
Data de registro
13/04/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/01/2021
Última transação
29/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
01/08/2006
Primeiro uso no comércio
10/08/2006
Código do desenho
4
Tipo de titular
16
Localização do titular
Lake Mary, FL
Examinador
PILARO,MARK F
Unidade examinadora
L40
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Clinical Research Holdings, LLC
Clinical Research Holdings, LLC
Representantes
Mark A. Wright McLane Middleton, P.A.
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALSPRE-CLINICAL THROUGH PHASE FOUR CLINICAL RESEARCH AND CLINICAL TRIAL MANAGEMENT SERVICESPRE-STUDY DOCUMENT COLLECTION AND REVIEWSITE SELECTIONVISITS AND AUDITSSITE COMPLIANCEPROJECT TRACKING AND MONITORING REPORTSNEGOTIATION AND ADMINISTRATION OF INVESTIGATOR GRANTS AND CLINICAL TRIAL BUDGETS AND CONTRACTSFINANCIAL AND MANAGEMENT ACCOUNTINGDISTRIBUTIONCOORDINATION AND TRACKING OF CLINICAL TRIAL PRODUCTS AND MATERIALSREGULATORY DOCUMENT PROCESSINGLABORATORY SELECTION AND COORDINATION; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALSPRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICESMANAGING SITE AND STUDY-SPECIFIC SUBJECT RECRUITMENT STRATEGIES AND PROGRAMS IN THE NATURE OF CONTINGENCY STRATEGIES AND SOLUTIONS TO ADDRESS SPECIFIC PROJECT CHALLENGES; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALSPRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICESMANAGING THE DEVELOPMENT OF ALL STUDY RELATED DOCUMENTS AND MATERIALS IN THE NATURE OF STUDY PROTOCOLSCONTRACTSBUDGETSAMENDMENTSPAPER AND ELECTRONIC CASE REPORT FORMSINFORMED CONSENT FORMSSAFETY NARRATIVESPRESENTATION POSTERSTRAINING MANUALS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALSPRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICESMANAGING ALL ASPECTS OF STUDYDRUG RECONCILIATIONINVENTORY AND DISTRIBUTION REPORTSMANAGING ALL ASPECTS OF CLINICAL TRIALSMANAGING INVESTIGATORSCOORDINATORSMONITORSTECHNICIANSPARTICIPANTSETHICAL REVIEWSINVESTIGATOR MEETINGSDATABASESSTATISTICAL ANALYSES AND REPORTINGRANDOMIZATION LOGISTICSRECRUITMENT OF INVESTIGATORSCOORDINATORSMONITORSTECHNICIANS AND PARTICIPANTS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALSPHASE ONE THROUGH PHASE FOUR ADMINISTRATION OF CLINICAL TRIAL MANAGEMENT SERVICESTHE ADMINISTRATION OF PROTOCOLS INVOLVING VOLUNTEER RESEARCH PATIENTS AND THE RECRUITING OF SUCH VOLUNTEER RESEARCH PATIENTS; PROVIDING DATA MANAGEMENT SERVICES IN THE MEDICALPHARMACEUTICAL AND BIOTECHNOLOGICAL FIELD
Classe 41
PROVIDING TRAINING IN THE FIELD OF CLINICAL TRIALS AND CLINICAL TRIAL MANAGEMENT FOR THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES
Classe 42
MEDICAL AND SCIENTIFIC RESEARCH CONSULTING REGARDING PRECLINICAL TO PHASE FOUR CLINICAL TRIALS; PROVIDING QUALITY ASSURANCE SERVICES IN THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES
Classe 45
REGULATORY AFFAIRSREVIEWING STANDARDS AND PRACTICES TO ASSURE COMPLIANCE WITH CLINICAL TRIAL LAWS AND REGULATIONS
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/01/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/01/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
12/10/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/04/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/06/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/06/2016
E815
TEAS SECTION 8 & 15 RECEIVED
28/03/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
13/04/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/01/2010
PUBO
PUBLISHED FOR OPPOSITION
26/01/2010
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
18/12/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/12/2009
ALIE
ASSIGNED TO LIE
05/12/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/11/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
18/11/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/11/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
18/11/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/11/2009
FAXX
FAX RECEIVED
06/11/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2009
GNRT
NON-FINAL ACTION E-MAILED
04/11/2009
CNRT
NON-FINAL ACTION WRITTEN
04/11/2009
DOCK
ASSIGNED TO EXAMINER
27/10/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/07/2009
NWAP
NEW APPLICATION ENTERED
28/07/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACCEL CLINICAL SERVICES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.